TRex Bio (TRXB) stock fell over 3% to $13.55 on Friday midday after its Nasdaq debut.
The biotech company priced its initial public offering of around 8.3 million common shares at $14 apiece for gross proceeds of $116.7 million.
The offering is expected to close on Oct. 13, the company said Thursday.
Price: 13.55, Change: -0.45, Percent Change: -3.21
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.